ONCOLOGY

Upcoming Events

9th Annual Childhood Cancer Symposium

A Virtual Event

 

This virtual conference is designed for physicians, nurses, nurse practitioners, pharmacists, physician assistants, child life specialists and social workers practicing in the field of pediatric and adult oncology or primary care. It will provide a learning opportunity to the health care community to expand their knowledge about treating their patients and bring to surface the real topics of discussion of today’s modern challenges. The day will end with a provocative patient driven discussion which will include a well-rounded parent panel and faculty interaction.

 

Complete conference details and registration information coming soon.

17th Annual New Orleans Summer Cancer Meeting – NOSCM

The Roosevelt Hotel
New Orleans, LA

 

The 17TH Annual New Orleans Summer Cancer Meeting (NOSCM) is the largest continuing medical education (CME) event in the US Southeast region. It is a 3-day national CME, nursing education (CE), pharmacist and physician assistant meeting designed for medical oncologists, hematologists, surgical oncologists, radiation oncologists, oncology nurses, nurse practitioners, pharmacists, physician assistants, residents, and fellows in Hematology/Oncology as well as other healthcare professionals involved in the management of cancer patients.

 

The 17th Annual NOSCM will have a long list of experts in the field of malignant diseases; guest faculty will discuss important topics in the management of cancer patients not only novel therapies such as immunotherapy, targeted agents, and cytotoxic agents but also the management of side effects, survivorship, palliative care, liquid biopsy, and biosimilars in oncology. The meeting will have deep discussions on immunotherapy for different tumor types. Immunotherapy has improved the overall survival of many tumor types; how to improve these outcomes and how to deal with immunotherapy resistance will be discussed during this educational activity.

 

For complete conference details, hotel and registration information please visit NOSCM.com

18th Annual California Cancer Consortium Conference (CCC)

The Langham Pasadena Hotel

Pasadena, California

 

This conference will bring together top oncologists for a comprehensive review and updated data in hematology, medical oncology, gynecology malignancies, immunotherapy, supportive care, healthcare policies and novel technologies in cancer management. This conference aims to provide up-to-date information to the clinician regarding new advances in cancer biology, diagnosis, and treatment. It will bring together respected opinion leaders, practicing clinicians and scientists engaged in clinical cancer research to discuss the latest cancer diagnostic and therapeutic advances.

 

For complete conference details, hotel and registration information please visit CCC 2022

MLS Nashville

Loews Vanderbilt Hotel

Nashville, Tennessee

 

This master lecture series will provide the most up-to-date, practical information on the management of breast cancer, lung cancer, gastrointestinal, genitourinary and melanoma in 2021. Immunotherapy and target therapies will be discussed in personalized treatments, and the latest clinical data impacting the management of these cancers. We will discuss the most current data in GI, GU (PARP Inhibitors), Melanoma (Immunotherapy/BRAF), Lung (RET/MET/VEGFR2) and breast cancer (HER2 P13K/Akt/TROP2).

 

Cutting edge lectures, panel discussions, multidisciplinary tumor boards with lively and collaborative question-and-answer sessions will provide a unique opportunity for participants to interact with faculty as they share their viewpoints and personal practices on the clinical challenges and ongoing controversies in managing cancer patients. The audience will engage in case-based discussions and critical deliberations on the state of current knowledge, clinical findings, differential diagnoses and management plan options for their patients.

 

For complete conference details, hotel and registration information please visit MLS Nashville

MLS Denver

Denver, Colorado

 

This master lecture series will provide the most up-to-date, practical information on the management of breast cancer, lung cancer, gastrointestinal, genitourinary and melanoma in 2021. Immunotherapy and target therapies will be discussed in personalized treatments, and the latest clinical data impacting the management of these cancers. We will discuss the most current data in GI, GU (PARP Inhibitors), Melanoma (Immunotherapy/BRAF), Lung (RET/MET/VEGFR2) and breast cancer (HER2 P13K/Akt/TROP2).

 

Cutting-edge lectures, panel discussions, multidisciplinary tumor boards with lively and collaborative question-and-answer sessions will provide a unique opportunity for participants to interact with faculty as they share their viewpoints and personal practices on the clinical challenges and ongoing controversies in managing cancer patients. The audience will engage in case-based discussions and critical deliberations on the state of current knowledge, clinical findings, differential diagnoses and management plan options for their patients.

 

For complete conference details, hotel and registration information please visit MLS Denver

MLS New Orleans

Westin New Orleans

New Orleans, LA

 

This master lecture series will provide the most up-to-date, practical information on the management of breast cancer, lung cancer, gastrointestinal, genitourinary, and melanoma in 2021. Immunotherapy and target therapies will be discussed in personalized treatments, and the latest clinical data impacting the management of these cancers. We will discuss the most current data in GI, GU (PARP Inhibitors), Melanoma (Immunotherapy/BRAF), Lung (RET/MET/VEGFR2), and breast cancer (HER2 P13K/Akt/TROP2).

 

Cutting-edge lectures, panel discussions, multidisciplinary tumor boards with lively and collaborative question-and-answer sessions will provide a unique opportunity for participants to interact with faculty as they share their viewpoints and personal practices on the clinical challenges and ongoing controversies in managing cancer patients. The audience will engage in case-based discussions and critical deliberations on the state of current knowledge, clinical findings, differential diagnoses, and management plan options for their patients.

For complete conference details, hotel and registration information please visit MLS New Orleans

Updates in Cancer Therapies | An ASCO | ESMO Review

Miami, Florida

 

Updates in Cancer Therapies: An ASCO/ESMO Review has been developed as a CME/CE activity focusing on the highlights of recent developments presented at this year’s two important international congresses delivering a clear and high-quality comprehensive educational program with key opinion leaders in each cancer field. This two-day live in person event will consist of presentations and questions & answer sessions on key topics in cancer care.

 

For complete conference details, hotel and registration information please visit Updates in Cancer Therapies website

23rd Advances in Oncology Conference

Kimpton Sawyer Hotel

Sacramento, California

 

As a result of prior course participant evaluations and needs assessment surveys, the need for cutting-edge information on prognostic markers and the appropriate application of novel therapies has been identified. This year’s conference will specifically address these needs in the common malignancies identified by past participants as essential to their practice, including solid and hematologic cancers. The timing of this meeting in the fall allows for the latest findings in clinical cancer research from major hematology and oncology conferences to be presented and discussed. This educational activity also meets a unique need for the Northern California Sacramento Valley to provide a group of networked and collaborating oncologists a forum to discuss the most recent developments in oncology care in the context of local treatment approaches, patient populations, and open clinical trials.

 

Complete conference information coming soon.

Best of WCLC 2022 San Francisco

Best of WCLC 2022 San Francisco

San Francisco, CA

 

The Best of WCLC is an educational initiative of the IASLC designed to present a multidisciplinary and multi-specialty approach to education, engaging both community and academic practitioners unable to attend the World Conference on Lung Cancer. The “Best of” program will condense the most exciting and practice-changing data from multiple disciplines into a single-day event (see agenda) to optimize information transfer from the WCLC to busy health

care professionals, with a focus on the most important advances in the care of patients with thoracic malignancies. The program is designed to increase attendee competency in the latest developments in the field, translating into improved practice patterns.

 

Complete conference information coming soon.

MLS San Francisco

San Francisco, CA

 

The lecture series will provide current, practical information on the management of immunotherapy and target therapies. We will discuss the novel agents and strategies with the potential to shape the future of cancer therapy. Leading experts will address critical topics in personalized therapy, and the latest clinical data impacting the treatment of GI, GU (PAR Inhibitors), melanoma, lung (RET/MET/ VEGFR2 & breast cancer (HER2 PI3K/Akt). The audience will engage in case-based discussions and critical deliberations on the state of current knowledge, clinical findings, differential diagnoses, and management plan options for their patients. This educational activity has been designed to meet the educational needs of medical oncologists, and health care professionals involved in the treatment of cancer.

 

Complete conference information coming soon.

8th Annual Practical Recommendations in Immuno & Molecular Oncology

Hilton Hawaiian Village
Honolulu, Hawaii

 

PRIMO is a unique opportunity to receive CME/CE credits while staying ahead of the latest advances in immuno and molecular oncology. The Annual PRIMO Meeting is designed to summarize key developments in cancer care over the past 12 months and features anticipated advances that you and your patients will likely see in the upcoming year.

 

Complete conference information coming soon.

12th Annual Winter Cancer Symposium

Rio Grande, Puerto Rico

 

The progress made in genomics, proteomic, oncogenic pathways and ultimately, development of new therapeutic targets continues moving quickly that there are so many paradigms shifts in cancer care that there is an on demand for up-to-date information.

 

This interprofessional activity is designed for physicians, advanced practice registered nurses, oncology nurses, physician assistants, pharmacists, and professionals in training from these disciplines to build a stronger collaborative partnership with other members of the cancer care team as well as oncology specialists.

 

This symposium strives to bridge the gap in patient outcomes, promoting and encouraging the forward synergy of this educational activity, bringing to the forefront novel therapies in oncology. Each session concludes with a round table and panel discussion maximizing faculty and attendee interaction.

 

Complete conference information coming soon.

19th Annual Miami Cancer Meeting

Miami, FL

 

Presentations from the latest national (AACR, ASCO, SABC, and ASH) and international forums (ESMO and WCLC) meetings will be discussed and guidelines of cancer care using a team approach will be emphasized. The participants in the conference will have the opportunity not only to learn, review, and understand the state-of-the-art management in cancer care using a team approach but also engage in personal interaction with our panel of experts in these subjects during the question-and-answer sessions.

 

Topics in solid tumors and hematological malignancies will be reviewed and will include topics in breast cancer, lung cancer, gastrointestinal (GI) malignancies, gynecologic malignancies, genitourinary (GU) cancers, head and neck cancers, melanoma, and hematological malignancies such as multiple myeloma, CLL and non-Hodgkin’s lymphoma. There will also be a special session devoted to the area of palliative care, survivorship in oncology, targeted therapy and immunotherapy side effects management.

 

The areas of focus for this conference will include the current standards of care in the treatment of all mentioned malignancies and new developments in these areas of cancer care. There will be much emphasis on molecular diagnosis and individualization of cancer therapy based on molecular profiles. There will be reviews of new chemotherapeutic, antiangiogenic, and immunotherapeutic agents.

 

Complete conference information coming soon.